Importantly, this study did not find a link between GLP-1 medications and NAION.
Receptor activation table The triple agonism of retatrutide is more than just a matter of combining mechanisms
Others may be curious because of cost considerations, access limitations, or a preference for gradual changes rather than rapid shifts in appetite or digestion
The randomised, double-blind, placebo-controlled study enrolled 2,339 adults with obesity or overweight and at least one weight-related health condition (such as high blood pressure or heart disease) but without diabetes
Retatrutide, with its broader receptor activity, holds the potential to amplify these cognitive effects, offering even stronger neuroprotection
Supports Healthy Blood Sugar GLP-1 helps the pancreas release insulin when blood sugar rises after eating